Kunihiko Tsuji

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

A case of transfusion‐transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food‐borne route

Keiji Matsubayashi, Jong‐Hon Kang, Hidekatsu Sakata et al. · Transfusion · 2008 · 288 citations

Medicine, Infectious Diseases, Microbiology +17

Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis

Atsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji et al. · Liver Cancer · 2018 · 245 citations · Full text

Medicine, Oncology, Diagnostic Pathology +15

Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications

Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo et al. · Liver Cancer · 2017 · 213 citations · Full text

Medicine, Oncology, Clinical Epidemiology +15

Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes

Hajime Yamazaki, Toru Tsuboya, Kunihiko Tsuji et al. · Diabetes Care · 2015 · 171 citations

Medicine, Health Sciences, Internal Medicine +17